<ѻý>Alzheimer’s Disease Linked to Altered Liver Enzymesѻý> "We have focused for too long on studying the brain in isolation" Jul 31, 2019
<ѻý>Lines Blur Between Non-Alcoholic and Alcoholic Fatty Liverѻý> Diagnostic criteria for disease types need updating for better patient stratification Jun 04, 2019
<ѻý>Pregnancy Complication More Common With NAFLDѻý> But inability to measure bile levels in control group could limit strength of association May 21, 2019
<ѻý>Promising Results with Givosiran in Acute Hepatic Porphyriasѻý> Patients on novel agent showed significant urinary ALA reduction versus placebo Apr 13, 2019
<ѻý>Combo Tx With 'Entry Inhibitor' Latest Hope in Treating Hep Dѻý> Myrcludex B and interferon shows promise in HBV/HDV co-infection Apr 12, 2019
<ѻý>Drug Shows Promise in Treating NASHѻý> Obeticholic acid improves fibrosis in interim phase III data Apr 11, 2019
<ѻý>Cirrhosis 'Turning Point' in Fatty Liver Progressionѻý> Most patients identified with decompensated event, real-world study finds Apr 11, 2019
<ѻý>Cure for Hepatitis B Pushedѻý> Disease affecting 257 million people needs better treatment Apr 10, 2019
<ѻý>High-Dose Albumin Cuts Cirrhotic Inflammation, Heart Dysfunctionѻý> Impact on inflammatory cytokines and circulation goes beyond plasma volume expansion Mar 26, 2019
<ѻý>What's Behind London's Falling HCV Rates in HIV+ MSM?ѻý> City cut HCV incidence in this population by almost 70% in 5 years Mar 08, 2019
<ѻý>'Incredibly Impressive' Activity in Biliary Ca with Combo Txѻý> Responses in about 40% of patients with BRAF/MEK inhibitor pairing Jan 20, 2019
<ѻý>MRI Proving Cost-Effective for Tracking Liver Fatѻý> But it's not ready to replace biopsy for assessing advanced disease Jan 02, 2019
<ѻý>HCV Combo Pill a Winner in Untreated Cirrhotic Patientsѻý> High SVR12 rate suggests 8-week treatment could be used for this population Nov 14, 2018
<ѻý>Minorities Sicker than Whites at Liver Transplant Referralѻý> Blacks had highest MELD scores at waitlist registration among racial-ethnic groups Nov 13, 2018
<ѻý>Novel Thyroid Beta Receptor Agonist Cut LDL-C in NAFLD Patientsѻý> Small phase II study also found reductions in liver fat vs placebo Nov 13, 2018
<ѻý>Regular Aspirin Use Tied to Reduction in HCC Riskѻý> Significant benefit apparent after ≥5 years of use at average dose of at least 1.5 tablets/week Nov 13, 2018
<ѻý>Do Patients with Chronic Liver Disease Face Higher DILI Risk?ѻý> Research suggests a link of which drug developers should be aware, expert says Nov 12, 2018
<ѻý>Hepatitis C Treatment Works Well for Young Kidsѻý> Nearly all children treated with sofosbuvir/ledipasvir achieved sustained response Nov 12, 2018
<ѻý>'De-Fatting' Tx May Give Discarded Livers New Lifeѻý> Ex vivo perfusion system plus therapy reduced fat in steatotic livers Nov 11, 2018
<ѻý>AASLD Poster Roundup: Gender, Insurance, Weight and Waitlistsѻý> Selections from poster sessions at the annual Liver Meeting Nov 10, 2018
<ѻý>Liver Meeting to Focus on Practice Matters Along with Scienceѻý> Topics range from 'day in the life' of a hepatology consultant to novel NASH therapies Nov 08, 2018
<ѻý>ACIP: Routinely Vaccinate Homeless Against HepAѻý> Homelessness denotes increased risk for contracting disease Oct 24, 2018
<ѻý>High-Dose Loop Diuretics Reduced Survival in Cirrhosisѻý> Faster muscle depletion and more deaths Sep 04, 2018
<ѻý>HIV May Up Risk for Liver Steatosis in Mono-infected Patientsѻý> Earlier intervention on 'manageable factors' for fatty liver disease may help in this population Jul 27, 2018
<ѻý>Gut-Liver-Brain Interactions Tied to Alzheimer’sѻý> Studies may explain mixed results of omega-3 trials Jul 26, 2018
<ѻý>Medicaid or No Insurance Tied to Higher Death Risk in HCVѻý> All public plans lead to higher mortality rates, according to 10-year study Jun 05, 2018
<ѻý>Hepatitis D: The 'Forgotten Virus' is Still Hereѻý> More attention to screening, treatment is needed, say experts Jun 04, 2018
<ѻý>Platelet Stimulator OK'd for Liver Disease Patients with Scheduled Proceduresѻý> Avatrombopag (Doptelet) is first drug approved for this indication May 21, 2018
<ѻý>Survival Prognosis Still Poor for Alcoholic Hepatitisѻý> Four decades of no improvement show urgent need for better treatments May 10, 2018
<ѻý>Biliary Fibrosis Stabilized with Obeticholic Acidѻý> Biopsy study supports anti-fibrosis properties of agent Apr 15, 2018
<ѻý>Hepatitis C Treatments Reduce Transplantsѻý> Therapies also appear to reduce liver-related mortality Apr 15, 2018
<ѻý>Europe Gets Updated HCV Tx Guidelinesѻý> EASL panel touts 'ease of use' of direct-acting antivirals Apr 15, 2018
<ѻý>SIRT + Sorafenib = No Survival Bump in Liver Cancerѻý> But clinical benefits suggested in certain patients with less severe disease Apr 15, 2018
<ѻý>A Role for Budesonide in Autoimmune Hepatitis?ѻý> Effective second-line treatment after prednisolone failure Jan 30, 2018
<ѻý>Combo Therapy Doubles PFS in Unresectable HCCѻý> Chemoembolization plus sorafenib tops embolization alone Jan 23, 2018
<ѻý>The Stiffer the Liver, The Worse the HF Prognosisѻý> Study suggests transient elastography of liver is prognostic Jan 17, 2018
<ѻý>Unlabeled Ingredients in 'Herbal' Supplements Seen Causing Liver Injuryѻý> Common culprits: body-building, weight-loss products Oct 24, 2017
<ѻý>Experts Raise Red Flag over Fatty Liver Diseaseѻý> Paints gloomy picture for population health, economy Oct 24, 2017
<ѻý>PBC Drug Promising in New Settingѻý> Lowers levels of enzyme in primary sclerosing cholangitis Oct 24, 2017
<ѻý>Lower is Better for PBC Candidate Drugѻý> Safety signal for seladelpar disappeared at lower doses Oct 24, 2017